Shinya Yamanaka

Summary

Affiliation: Kyoto University
Country: Japan

Publications

  1. ncbi Elite and stochastic models for induced pluripotent stem cell generation
    Shinya Yamanaka
    Center for iPS Cell Research and Application CiRA, Kyoto University, Kyoto 606 8507, Japan
    Nature 460:49-52. 2009
  2. ncbi Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice
    Shinji Kaichi
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Cardiovasc Res 88:314-23. 2010
  3. ncbi Generation of pluripotent stem cells from adult mouse liver and stomach cells
    Takashi Aoi
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Science 321:699-702. 2008
  4. ncbi Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
    Hyenjong Hong
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Nature 460:1132-5. 2009
  5. ncbi Generation of mouse induced pluripotent stem cells without viral vectors
    Keisuke Okita
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Science 322:949-53. 2008
  6. ncbi Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells
    Masayoshi Maruyama
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    J Biol Chem 280:24371-9. 2005
  7. ncbi Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts
    Noriko Tsubooka
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Genes Cells 14:683-94. 2009
  8. ncbi Generation of mouse-induced pluripotent stem cells with plasmid vectors
    Keisuke Okita
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto, Japan
    Nat Protoc 5:418-28. 2010
  9. ncbi Variation in the safety of induced pluripotent stem cell lines
    Kyoko Miura
    Center for iPS Cell Research and Application CiRA, Kyoto University, Kyoto, Japan
    Nat Biotechnol 27:743-5. 2009
  10. ncbi Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
    Masato Nakagawa
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Nat Biotechnol 26:101-6. 2008

Collaborators

Detail Information

Publications48

  1. ncbi Elite and stochastic models for induced pluripotent stem cell generation
    Shinya Yamanaka
    Center for iPS Cell Research and Application CiRA, Kyoto University, Kyoto 606 8507, Japan
    Nature 460:49-52. 2009
    ..Here I consider reasons for bottlenecks in induced pluripotent stem cell generation, and propose a model in which most or all cells have the potential to become pluripotent...
  2. ncbi Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice
    Shinji Kaichi
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Cardiovasc Res 88:314-23. 2010
    ..iPS cells can be generated even without the expression of c-Myc. The present study examined patterns of differentiation of mouse iPS cells into cardiomyocytes in three different cell lines reprogrammed by three or four factors...
  3. ncbi Generation of pluripotent stem cells from adult mouse liver and stomach cells
    Takashi Aoi
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Science 321:699-702. 2008
    ..These data suggest that iPS cells are generated by direct reprogramming of lineage-committed somatic cells and that retroviral integration into specific sites is not required...
  4. ncbi Suppression of induced pluripotent stem cell generation by the p53-p21 pathway
    Hyenjong Hong
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Nature 460:1132-5. 2009
    ..Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation...
  5. ncbi Generation of mouse induced pluripotent stem cells without viral vectors
    Keisuke Okita
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Science 322:949-53. 2008
    ..The production of virus-free iPS cells, albeit from embryonic fibroblasts, addresses a critical safety concern for potential use of iPS cells in regenerative medicine...
  6. ncbi Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells
    Masayoshi Maruyama
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    J Biol Chem 280:24371-9. 2005
    ..Taken together, these data demonstrate differential roles for Sox15 and Sox2 in transcriptional control in mouse ES cells...
  7. ncbi Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts
    Noriko Tsubooka
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Genes Cells 14:683-94. 2009
    ..These results demonstrated that Sall4 plays positive roles in the generation of pluripotent stem cells from blastocysts and fibroblasts...
  8. ncbi Generation of mouse-induced pluripotent stem cells with plasmid vectors
    Keisuke Okita
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto, Japan
    Nat Protoc 5:418-28. 2010
    ..This virus-free technique reduces the safety concern for iPS cell generation and application, and provides a source of cells for the investigation of the mechanisms underlying reprogramming and pluripotency...
  9. ncbi Variation in the safety of induced pluripotent stem cell lines
    Kyoko Miura
    Center for iPS Cell Research and Application CiRA, Kyoto University, Kyoto, Japan
    Nat Biotechnol 27:743-5. 2009
    ..In contrast, SNS from iPS cells derived from different adult tissues varied substantially in their teratoma-forming propensity, which correlated with the persistence of undifferentiated cells...
  10. ncbi Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
    Masato Nakagawa
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Nat Biotechnol 26:101-6. 2008
    ..The protocol also enabled efficient isolation of iPS cells without drug selection. Furthermore, we generated human iPS cells from adult dermal fibroblasts without MYC...
  11. ncbi Induction of pluripotent stem cells from adult human fibroblasts by defined factors
    Kazutoshi Takahashi
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Cell 131:861-72. 2007
    ..Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts...
  12. ncbi Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells
    Koichiro Homma
    Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto 606 8507, Japan
    Atherosclerosis 212:42-7. 2010
    ..Here, we compared the functionality of human adult ECs (HAECs), human ES-derived ECs (ESECs) and human iPS-derived ECs (iPSECs)...
  13. ncbi Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells
    Shogo Nagata
    Stem Cell Engineering, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara cho, Shogoin, Sakyo ku, Kyoto 606 8507, Japan
    Genes Cells 14:1395-404. 2009
    ....
  14. ncbi A more efficient method to generate integration-free human iPS cells
    Keisuke Okita
    Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
    Nat Methods 8:409-12. 2011
    ..This method may provide iPSCs suitable for autologous and allologous stem-cell therapy in the future...
  15. ncbi Promotion of direct reprogramming by transformation-deficient Myc
    Masato Nakagawa
    Center for iPS Cell Research and Application, Kyoto University, Kyoto 606 8507, Japan
    Proc Natl Acad Sci U S A 107:14152-7. 2010
    ..These data demonstrate that different functional moieties of the Myc proto-oncogene products are involved in the transformation and promotion of directed reprogramming...
  16. ncbi Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors
    Akira Niwa
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    J Cell Physiol 221:367-77. 2009
    ..This finding highlights the potential use of iPS cells in clinical areas such as regenerative medicine, disease investigation, and drug screening...
  17. ncbi Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells
    Daisuke Taura
    Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Sakyo ku, Kyoto 606 8507, Japan
    FEBS Lett 583:1029-33. 2009
    ..These results demonstrate that human iPS cells have an adipogenic potential comparable to human ES cells...
  18. ncbi Induction of pluripotent stem cells from fibroblast cultures
    Kazutoshi Takahashi
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara machi, Shogoin, Sakyo ku, Kyoto 606 8507, Japan
    Nat Protoc 2:3081-9. 2007
    ..The cells, named induced pluripotent stem (iPS) cells, can be differentiated into three germ layers and committed to chimeric mice. Here we describe detailed methods and tips for the generation of iPS cells...
  19. ncbi Generation of germline-competent induced pluripotent stem cells
    Keisuke Okita
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Nature 448:313-7. 2007
    ..Thus, iPS cells competent for germline chimaeras can be obtained from fibroblasts, but retroviral introduction of c-Myc should be avoided for clinical application...
  20. ncbi Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells
    Genta Narazaki
    Laboratory of Stem Cell Differentiation, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Circulation 118:498-506. 2008
    ..However, detailed differentiation properties and the directional differentiation system of iPS cells have not been demonstrated...
  21. ncbi ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSC generation, but it is dispensable for the maintenance and induction of pluripotency
    Kumiko A Iwabuchi
    Center for iPS Cell Research and Application CiRA, Kyoto University, Kyoto, Japan
    PLoS ONE 6:e20461. 2011
    ..However, iPS cells could be established from ECAT11-null fibroblasts. Our data demonstrate the dispensability of ECAT11/L1td1 in pluripotency, despite its specific expression...
  22. ncbi Transplantation of mouse induced pluripotent stem cells into the cochlea
    Koji Nishimura
    Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606 8507, Japan
    Neuroreport 20:1250-4. 2009
    ..Some transplants expressed vesicular glutamate transporter 1, which is a marker for glutamatergic neurons. These findings indicate that iPS cells can be used as a source of transplants for the regeneration of spiral ganglion neurons...
  23. ncbi The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
    Noritaka Yokoo
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, 54 Kawahara cho, Shogoin, Sakyo ku, Kyoto, Japan
    Biochem Biophys Res Commun 387:482-8. 2009
    ..Thus, human iPS cells could become an attractive tool to investigate the effects of cardioactive drugs at the individual level and to screen for individually tailored drugs against cardiac arrhythmic diseases...
  24. ncbi Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1
    Momoko Maekawa
    Center for iPS Cell Research and Application, Kyoto University, Kyoto 606 8507, Japan
    Nature 474:225-9. 2011
    ..These results therefore show that Glis1 effectively promotes the direct reprogramming of somatic cells during iPSC generation...
  25. ncbi Generation and characterization of human induced pluripotent stem cells
    Mari Ohnuki
    Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto, Japan
    Curr Protoc Stem Cell Biol . 2009
    ..RT-PCR and immunocytochemistry for detection of pluripotent cell markers, embryoid body differentiation, and teratoma differentiation are used to determine pluripotency in vitro and in vivo, respectively...
  26. ncbi Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression
    Hideki Uosaki
    Laboratory of Stem Cell Differentiation, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
    PLoS ONE 6:e23657. 2011
    ..In this study, we attempted to identify cell surface markers for cardiomyocytes derived from hESC/hiPSCs...
  27. ncbi Human induced pluripotent stem cells on autologous feeders
    Kazutoshi Takahashi
    Center for iPS Cell Research and Application, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto, Japan
    PLoS ONE 4:e8067. 2009
    ..Instead of animal feeders, human fibroblasts can be used as feeder cells of human ES cells. However, one still has to be concerned about the existence of unidentified pathogens, such as viruses and prions in these non-autologous feeders...
  28. ncbi Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A
    Masataka Fujiwara
    Laboratory of Stem Cell Differentiation, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
    PLoS ONE 6:e16734. 2011
    ..These results provide a technological basis to obtain functional cardiomyocytes from iPSCs...
  29. ncbi Essential roles of ECAT15-2/Dppa2 in functional lung development
    Tomonori Nakamura
    Center for iPS Cell Research and Application CiRA, Kyoto University, Kyoto 606 8507, Japan
    Mol Cell Biol 31:4366-78. 2011
    ..These data suggest that ECAT15-2 has important roles in lung development, where it is no longer expressed, by leaving epigenetic marks from earlier developmental stages...
  30. ncbi Pluripotency and nuclear reprogramming
    Shinya Yamanaka
    Center for iPS Cell Research and Application, Kyoto University, Kyoto 606 8507, Japan
    Philos Trans R Soc Lond B Biol Sci 363:2079-87. 2008
    ..Here, we review the molecular mechanisms underlying pluripotency and the currently known methods of inducing pluripotency in somatic cells...
  31. ncbi Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells
    Masanori Imamura
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    BMC Dev Biol 6:34. 2006
    ..We previously identified a set of genes called ECATs (ES cell-associated transcripts) that are expressed at high levels in mouse ES cells. Here, we examine the expression and DNA methylation of ECATs in somatic cells and germ cells...
  32. ncbi [Molecular mechanisms underlying pluripotency of embryonic stem cells]
    Shinya Yamanaka
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    Seikagaku 78:27-33. 2006
  33. ncbi [Induction of pluripotent stem cells from mouse fibroblast cultures]
    Shinya Yamanaka
    Tanpakushitsu Kakusan Koso 51:2346-51. 2006
  34. ncbi Intracellular signaling pathways regulating pluripotency of embryonic stem cells
    Keisuke Okita
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
    Curr Stem Cell Res Ther 1:103-11. 2006
    ..We will review the rapid progress that has been made in identifying and dissecting the intracellular signaling pathways that contribute to self-renewal of pluripotent mouse and human ES cells...
  35. ncbi Nuclear reprogramming to a pluripotent state by three approaches
    Shinya Yamanaka
    Center for iPS Cell Research and Application, Kyoto University, Kyoto 606 8507, Japan
    Nature 465:704-12. 2010
    ..This remarkable discovery of cellular plasticity has important medical applications...
  36. ncbi Induced pluripotent stem cells: opportunities and challenges
    Keisuke Okita
    Center for iPS Cell Research and Application, Kyoto University, Kyoto 606 8507, Japan
    Philos Trans R Soc Lond B Biol Sci 366:2198-207. 2011
    ..This report will summarize the current knowledge of iPS generation and discuss future reprogramming methods for medical application...
  37. ncbi Utilization of digital differential display to identify novel targets of Oct3/4
    Yoshimi Tokuzawa
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
    Methods Mol Biol 329:223-31. 2006
    ..Reporter gene and gel mobility shift assays are used to confirm the role of Oct3/4. Identification of novel Oct3/4 targets will facilitate our understanding of pluripotency...
  38. ncbi Anti-A? drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease
    Naoki Yahata
    Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
    PLoS ONE 6:e25788. 2011
    ..Induced pluripotent stem (iPS) cells potentially provide an opportunity to generate a human cell-based model of AD that would be crucial for drug discovery as well as for investigating mechanisms of the disease...
  39. ncbi iPS cells: a source of cardiac regeneration
    Yoshinori Yoshida
    Center for iPS Cell Research and Application, Kyoto University, Sakyo ku, Kyoto, Japan
    J Mol Cell Cardiol 50:327-32. 2011
    ..This article is part of a special issue entitled, "Cardiovascular Stem Cells Revisited"...
  40. ncbi A fresh look at iPS cells
    Shinya Yamanaka
    Center for iPS Cell Research and Application, Kyoto University, Kyoto 606 8507, Japan
    Cell 137:13-7. 2009
    ..The potential of induced pluripotent stem (iPS) cells is enormous, but many obstacles remain before their medical and pharmaceutical applications can be fully realized...
  41. ncbi Strategies and new developments in the generation of patient-specific pluripotent stem cells
    Shinya Yamanaka
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606 8507, Japan
    Cell Stem Cell 1:39-49. 2007
    ..Taken together, these studies underscore the crucial roles of transcription factors and chromatin remodeling in nuclear reprogramming...
  42. ncbi [Research for cell therapy by induced pluripotent stem cell]
    Hidetoshi Sakurai
    Center for iPS Cell Research and Application CiRA, Kyoto University
    Nihon Rinsho 69:2114-8. 2011
    ..This review is also focused on new strategies for reducing a risk of tumorigenesis...
  43. ncbi Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
    Kazutoshi Takahashi
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan
    Cell 126:663-76. 2006
    ..These data demonstrate that pluripotent stem cells can be directly generated from fibroblast cultures by the addition of only a few defined factors...
  44. ncbi Reprogramming somatic cells towards pluripotency by defined factors
    Marc Lewitzky
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, 53 Kawahara cho, Shogoin, Sakyo ku, Kyoto 606 8507, Japan
    Curr Opin Biotechnol 18:467-73. 2007
    ..The re-programmed cells contribute to live chimeric mice and are transmitted via the germline...
  45. ncbi Induction of pluripotency by defined factors
    Keisuke Okita
    Center for iPS Cell Research and Application CiRA, Institute for Integrated Cell Material Sciences, Kyoto University, Kyoto 606 8507, Japan
    Exp Cell Res 316:2565-70. 2010
    ..On the other hand, patient-specific iPS cells have already been established and used for recapitulating disease pathology...
  46. ncbi Reprogramming of somatic cells to pluripotency
    Masato Nakagawa
    Center for iPS Research and Application Institute for Integrated Cell Material Sciences, Kyoto University, 53 Kawahara cho, Shogoin, Sakyo ku, Kyoto, 606 8507, Japan
    Adv Exp Med Biol 695:215-24. 2010
    ....
  47. ncbi Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway
    Kazutoshi Takahashi
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University and CREST, Japan Science and Technology Agency, Kyoto 606 8507, Japan
    J Biol Chem 280:32768-74. 2005
    ..Rheb also shares the same membrane-targeting pathway but because of the absence of palmitoylation is located on endomembranes...
  48. ncbi Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5)
    Hisayuki Amano
    Department of Stem Cell Biology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
    BMC Dev Biol 6:11. 2006
    ..Previous studies identified genomic clones containing the mouse ESG1 gene and five pseudogenes. However, their chromosomal localizations or physiological functions have not been determined...